Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC00316 (Long intergenic non-protein coding RNA 316) is a human long non-coding RNA gene located at chromosome 21q22.3[3][5]. It is also referred to as C21orf111, NCRNA00316, and PRED59[5]. LINC00316 encodes a transcript that does not translate into a protein and falls into the broader category of long non-coding RNAs (lncRNAs), which are known for diverse regulatory roles in gene expression. As of now, the specific biological function and clinical relevance of LINC00316 remain uncharacterized, and it has not been identified as a therapeutic target, biomarker, or disease-associated gene in the current literature[1][3][5].
None reported
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 316 (LINC00316).